USP6: A Protein with Promising Potential as A Drug Target Or Biomarker

Target Name: USP6

NCBI ID: G9098

USP6

USP6: A Protein with Promising Potential as A Drug Target Or Biomarker

USP6 (Unconventional Secreted Protein 6) is a protein that is expressed in various tissues of the body, including the brain, pancreas, and gastrointestinal tract. It is characterized by its unique structure, which consists of a long amino acid sequence with a hydrophobic region and a hydrophilic region. Despite its unique features, USP6 is not well understood, and its functions are still being explored.

One of the most promising aspects of USP6 is its potential as a drug target or biomarker. The USP6 protein has been shown to play a role in various physiological processes, including cell signaling, tissue repair, and inflammation. USP6 has also been shown to interact with several other proteins, including TGF-β1, a known regulator of cell signaling.

One potential mechanism by which USP6 could be targeted as a drug is its role in cell signaling. USP6 has been shown to play a negative role in the development of cancer, and it has been shown to promote the growth and survival of cancer cells. By inhibiting the activity of USP6, it may be possible to reduce the growth and survival of cancer cells.

Another potential mechanism by which USP6 could be targeted as a drug is its role in tissue repair. USP6 has been shown to play a role in the repair of damaged tissue, and it has been shown to promote the formation of new tissue in the aftermath of injury. By increasing the formation of new tissue, USP6 may be a potential drug target for tissue repair disorders.

In addition to its potential as a drug target, USP6 also has potential as a biomarker. The unique structure of USP6 makes it a potentially interesting protein for study, and it may be possible to use USP6 as a biomarker for various diseases. For example, USP6 has been shown to be expressed in the brains of individuals with Alzheimer's disease, and it has been suggested that it may play a role in the development and progression of this disease.

Overall, USP6 is a protein that is still being explored for its functions and potential as a drug target or biomarker. Further research is needed to fully understand the role of USP6 in various physiological processes, and to determine its potential as a drug.

Protein Name: Ubiquitin Specific Peptidase 6

Functions: Deubiquitinase with an ATP-independent isopeptidase activity, cleaving at the C-terminus of the ubiquitin moiety. Catalyzes its own deubiquitination. In vitro, isoform 2, but not isoform 3, shows deubiquitinating activity. Promotes plasma membrane localization of ARF6 and selectively regulates ARF6-dependent endocytic protein trafficking. Is able to initiate tumorigenesis by inducing the production of matrix metalloproteinases following NF-kappa-B activation

The "USP6 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about USP6 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets